Similar articles

• Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients.

  Morgenstern KE, Vadysirisack DD, Zhang Z, Cahill KV, Foster JA, Burns JA, Kloos RT, Jhiang SM. Morgenstern KE, et al. Ophthalmic Plast Reconstr Surg. 2005 Sep;21(5):337-44. doi: 10.1097/01.iop.0000179369.75569.a8. Ophthalmic Plast Reconstr Surg. 2005. PMID: 16234694
• [Lacrimal drainage system obstruction associated to radioactive iodine therapy for thyroid carcinoma].

  Fonseca FL, Lunardelli P, Matayoshi S. Fonseca FL, et al. Arq Bras Oftalmol. 2012 Mar-Apr;75(2):97-100. doi: 10.1590/s0004-27492012000200005. Arq Bras Oftalmol. 2012. PMID: 22760799 Portuguese.
• Salivary gland dysfunction and nasolacrimal duct obstruction: stenotic changes following I-131 therapy.

  Savage MW, Sobel RK, Hoffman HT, Carter KD, Finkelstein MW, Shriver EM. Savage MW, et al. Ophthalmic Plast Reconstr Surg. 2015 May-Jun;31(3):e50-2. doi: 10.1097/IOP.0000000000000066. Ophthalmic Plast Reconstr Surg. 2015. PMID: 24836449
• Update on lacrimal apparatus dysfunction associated with differentiated thyroid cancer after I-131 therapy.

  Liang C, Wu C, Liu L, Zhong J. Liang C, et al. Int Ophthalmol. 2024 Jun 23;44(1):257. doi: 10.1007/s10792-024-03192-9. Int Ophthalmol. 2024. PMID: 38909080 Review.
• Nasolacrimal drainage obstruction after radioiodine therapy: case report and a review of the literature.

  Brockmann H, Wilhelm K, Joe A, Palmedo H, Biersack HJ. Brockmann H, et al. Clin Nucl Med. 2005 Aug;30(8):543-5. doi: 10.1097/01.rlu.0000170013.84378.2a. Clin Nucl Med. 2005. PMID: 16024949 Review.